Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Psoriasis: HELP
Daniëlle M. Gerlag
Based on 15 articles published since 2008
||||
Expertise Level
The expertise of Daniëlle M. Gerlag ranks in the
  • Top 1.6%
  • ... of 37,573 published authors worldwide on Psoriasis
  • ... from 2008 through 2019
  • ... based on contributions to 15 articles on the topic.
Graphical view (beta)
Uncounted papers?
Aliases Gerlag, D M   ·   Gerlag, Danielle M   ·   Gerlag, Daniëlle M   ·   Gerlag, Danielle   ·   Gerlag, D
Work Locations
Details
Most likely:    University of Amsterdam      
2017
  • Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; · Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · GlaxoSmithKline, Cambridge, United Kingdom. · GlaxoSmithKline, Stevenage, United Kingdom. · Department of Rheumatology, Ghent University, Ghent, Belgium; and. · Department of Rheumatology, University of Cambridge, Cambridge, United Kingdom. · Pubmed 28642278
2016
  • Division of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center/University of Amsterdam, Amsterdam, the Netherlands, · Department of Experimental Immunology, Academic Medical Center/University of Amsterdam, the Netherlands. · Division of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center/University of Amsterdam, Amsterdam, the Netherlands. · Inserm, Inserm U1151, Institut Necker Enfants Malades, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Division of Vascular Medicine, Academic Medical Center/University of Amsterdam, Amsterdam, the Netherlands. · Pubmed 27616146
  • School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin, Ireland. · Department of Rheumatology, St Vincent's University Hospital, Elm Park, Dublin, Ireland. · Northern Ireland Centre for Stratified Medicine, University of Ulster, C-TRIC, Londonderry, UK. · Department of Clinical Immunology and Rheumatology, F4-105, Academic Medical Centre/University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 26108918
  • UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland. · UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland UCD School of Mathematical Sciences, University College Dublin, Dublin, Ireland. · UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland Department of Rheumatology, St. Vincent's University Hospital Dublin, Dublin, Ireland. · Department of Clinical Immunology/Rheumatology, Academic Medical Centre/University of Amsterdam, Amsterdam, Netherlands. · Pubmed 25187158
2015
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. Electronic address: · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of rheumatology, Flevoziekenhuis, Hospitaalweg 1, 1315 RA Almere, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of Rheumatology, Atrium Medical Center, Postbus 4446, 6401 CX Heerlen, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands; GlaxoSmithKline, Stevenage, UK; University of Cambridge, Cambridge, UK; Ghent University, Ghent, Belgium. · Pubmed 26188879
  • Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands. · Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Cambridge, UK. · Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Research and Development, CSL Limited, Parkville, Victoria, Australia. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Stevenage, UK University of Cambridge, Cambridge, UK. · Pubmed 24936585
2015
  • From the Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; Arthrogen B.V., Amsterdam; Department of Rheumatology, Atrium Medical Center, Heerlen, the Netherlands.C.J. Aalbers, MD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V.; D.M. Gerlag, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; M.J. Vervoordeldonk, PhD, Arthrogen B.V.; P.P. Tak, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V., and GlaxoSmithKline, and University of Cambridge; R.B. Landewé, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Department of Rheumatology, Atrium Medical Center. · Pubmed 26178282
2010
  • Division of Clinical Immunology and Rheumatology, F4-218, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 20844595
2009
  • University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 19877042
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 18647851
Probable:    GlaxoSmithKline      
2017
  • Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; · Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · GlaxoSmithKline, Cambridge, United Kingdom. · GlaxoSmithKline, Stevenage, United Kingdom. · Department of Rheumatology, Ghent University, Ghent, Belgium; and. · Department of Rheumatology, University of Cambridge, Cambridge, United Kingdom. · Pubmed 28642278
2015
  • Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands. · Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Cambridge, UK. · Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Research and Development, CSL Limited, Parkville, Victoria, Australia. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Stevenage, UK University of Cambridge, Cambridge, UK. · Pubmed 24936585
2015
  • From the Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; Arthrogen B.V., Amsterdam; Department of Rheumatology, Atrium Medical Center, Heerlen, the Netherlands.C.J. Aalbers, MD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V.; D.M. Gerlag, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; M.J. Vervoordeldonk, PhD, Arthrogen B.V.; P.P. Tak, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V., and GlaxoSmithKline, and University of Cambridge; R.B. Landewé, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Department of Rheumatology, Atrium Medical Center. · Pubmed 26178282
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 15 total) written by Daniëlle M. Gerlag about Psoriasis:

  • Rheumatoid arthritis and psoriatic arthritis synovial fluids stimulate prolactin production by macrophages. 2017
  • The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation. 2016
  • Reduced CLEC9A expression in synovial tissue of psoriatic arthritis patients after adalimumab therapy. 2016
  • A clinically based protein discovery strategy to identify potential biomarkers of response to anti-TNF-α treatment of psoriatic arthritis. 2016
  • Discovery and confirmation of a protein biomarker panel with potential to predict response to biological therapy in psoriatic arthritis. 2016
  • Intra-articular etanercept treatment in inflammatory arthritis: A randomized double-blind placebo-controlled proof of mechanism clinical trial validating TNF as a potential therapeutic target for local treatment. 2015
  • Single-joint Assessment for the Evaluation of Intraarticular Treatment: Responsiveness and Discrimination of the Composite Change Index. 2015
  • Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis. 2015
  • Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy? 2014
  • Expression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatment. 2012
Show List of Full Article Records
Google Searches

Learn more about Daniëlle M. Gerlag using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Amsterdam
GlaxoSmithKline
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Amsterdam
2017
  • Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; · Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · GlaxoSmithKline, Cambridge, United Kingdom. · GlaxoSmithKline, Stevenage, United Kingdom. · Department of Rheumatology, Ghent University, Ghent, Belgium; and. · Department of Rheumatology, University of Cambridge, Cambridge, United Kingdom. · Pubmed 28642278
2016
  • Division of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center/University of Amsterdam, Amsterdam, the Netherlands, · Department of Experimental Immunology, Academic Medical Center/University of Amsterdam, the Netherlands. · Division of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center/University of Amsterdam, Amsterdam, the Netherlands. · Inserm, Inserm U1151, Institut Necker Enfants Malades, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Division of Vascular Medicine, Academic Medical Center/University of Amsterdam, Amsterdam, the Netherlands. · Pubmed 27616146
  • School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin, Ireland. · Department of Rheumatology, St Vincent's University Hospital, Elm Park, Dublin, Ireland. · Northern Ireland Centre for Stratified Medicine, University of Ulster, C-TRIC, Londonderry, UK. · Department of Clinical Immunology and Rheumatology, F4-105, Academic Medical Centre/University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 26108918
  • UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland. · UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland UCD School of Mathematical Sciences, University College Dublin, Dublin, Ireland. · UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland Department of Rheumatology, St. Vincent's University Hospital Dublin, Dublin, Ireland. · Department of Clinical Immunology/Rheumatology, Academic Medical Centre/University of Amsterdam, Amsterdam, Netherlands. · Pubmed 25187158
2015
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. Electronic address: · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of rheumatology, Flevoziekenhuis, Hospitaalweg 1, 1315 RA Almere, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of Rheumatology, Atrium Medical Center, Postbus 4446, 6401 CX Heerlen, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands; GlaxoSmithKline, Stevenage, UK; University of Cambridge, Cambridge, UK; Ghent University, Ghent, Belgium. · Pubmed 26188879
  • Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands. · Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Cambridge, UK. · Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Research and Development, CSL Limited, Parkville, Victoria, Australia. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Stevenage, UK University of Cambridge, Cambridge, UK. · Pubmed 24936585
2015
  • From the Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; Arthrogen B.V., Amsterdam; Department of Rheumatology, Atrium Medical Center, Heerlen, the Netherlands.C.J. Aalbers, MD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V.; D.M. Gerlag, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; M.J. Vervoordeldonk, PhD, Arthrogen B.V.; P.P. Tak, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V., and GlaxoSmithKline, and University of Cambridge; R.B. Landewé, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Department of Rheumatology, Atrium Medical Center. · Pubmed 26178282
2010
  • Division of Clinical Immunology and Rheumatology, F4-218, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 20844595
2009
  • University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 19877042
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 18647851
GlaxoSmithKline
2017
  • Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; · Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · GlaxoSmithKline, Cambridge, United Kingdom. · GlaxoSmithKline, Stevenage, United Kingdom. · Department of Rheumatology, Ghent University, Ghent, Belgium; and. · Department of Rheumatology, University of Cambridge, Cambridge, United Kingdom. · Pubmed 28642278
2015
  • Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands. · Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Cambridge, UK. · Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Research and Development, CSL Limited, Parkville, Victoria, Australia. · Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Stevenage, UK University of Cambridge, Cambridge, UK. · Pubmed 24936585
2015
  • From the Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; Arthrogen B.V., Amsterdam; Department of Rheumatology, Atrium Medical Center, Heerlen, the Netherlands.C.J. Aalbers, MD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V.; D.M. Gerlag, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam; M.J. Vervoordeldonk, PhD, Arthrogen B.V.; P.P. Tak, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Arthrogen B.V., and GlaxoSmithKline, and University of Cambridge; R.B. Landewé, MD, PhD, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, and Department of Rheumatology, Atrium Medical Center. · Pubmed 26178282
Unspecified
2016
  • Clinical Immunology and Rheumatology Department Experimental Immunology Department. · Dermatology Department, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Clinical Immunology and Rheumatology Department. · Clinical Immunology and Rheumatology Department Experimental Immunology Department · Pubmed 27179104
3 Other Locations Show
Yearly article counts 001431021120
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.